NBSE — NeuBase Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for NeuBase Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 September 30th	2020 September 30th	2021 September 30th	2022 September 30th	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	3 M
Source:	10-K	10-K	10-K	10-K	10-Q
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	10.3	32	52.9	23.2	17.4
Net Total Accounts Receivable
Net Total Receivables	—	—	—	—	0.15
Prepaid Expenses
Total Current Assets	11	32.8	54.9	24.6	18
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.431	1.17	8.41	7.77	7.34
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	12.5	34.4	64.2	32.7	25.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.5	3.15	4.19	4.17	2.15
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2.5	3.15	10.1	9.5	7.36
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	10	31.3	54.1	23.2	18.2
Total Liabilities & Shareholders' Equity	12.5	34.4	64.2	32.7	25.6
Total Common Shares Outstanding
Total Preferred Shares Outstanding